CLENOST Trademark

Trademark Overview


On Tuesday, February 25, 2020, a trademark application was filed for CLENOST with the United States Patent and Trademark Office. The USPTO has given the CLENOST trademark a serial number of 88810001. The federal status of this trademark filing is REGISTERED as of Tuesday, March 2, 2021. This trademark is owned by Glaxo Group Limited. The CLENOST trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
clenost

General Information


Serial Number88810001
Word MarkCLENOST
Filing DateTuesday, February 25, 2020
Status700 - REGISTERED
Status DateTuesday, March 2, 2021
Registration Number6280345
Registration DateTuesday, March 2, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 15, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 28, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Friday, October 28, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 28, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, October 28, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 2, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, December 15, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 15, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 25, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, November 9, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, October 29, 2020NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, October 29, 2020LETTER OF SUSPENSION E-MAILED
Thursday, October 29, 2020SUSPENSION LETTER WRITTEN
Saturday, October 10, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 9, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 9, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, May 12, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 12, 2020NON-FINAL ACTION E-MAILED
Tuesday, May 12, 2020NON-FINAL ACTION WRITTEN
Thursday, May 7, 2020ASSIGNED TO EXAMINER
Friday, February 28, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 28, 2020NEW APPLICATION ENTERED IN TRAM